Location: Home /  About MGI

MGI Responds to Illumina's Motion for a Preliminary Injunction in United States

Release date:2020-02-21Writer:MGIViews:3336Share

MGI responded today to a motion filed by Illumina in the US District Court for the Northern District of California for a preliminary injunction to try to prevent MGI from distributing sequencers in the US, saying Illumina’s motion is without merit.


Illumina's motion for a preliminary injunction is not directed to MGI's novel CoolMPS reagent kits or the use of MGI's sequencers with the CoolMPS reagent kits.  Rather, Illumina's motion is directed at preventing even minimal use of MGI’s reagent kits for comparison with MGI's CoolMPS chemistry. Thus, MGI believes that this motion is an example of Illumina attempting to tarnish MGI’s reputation, stifle competition, and limit consumer choice in the U.S. market. 

  • Hotline (Global)
    +86-4000-688-114
  • Email
    MGI-service@mgi-tech.com
  • Special Recommendations
  • *For research use only.

    Not for use in diagnostic procedures (except as specifically noted).
Copyright © 2024 All Rights Reserved MGI Tech Co., Ltd. Guangdong ICP 16117185Privacy PolicyLegal NoticesCookie Policy
Our use of cookies
We would like to use necessary cookies to improve your browsing experience and the quality of our website. We would also like to set analytics cookies and advertisement cookies that help us make improvements by measuring how you use our website. Detailed information about the use of cookies on this website and how you can control your consent can be found in our Cookie Policy and Privacy Policy.
Accept only strictly necessary cookiesAccept all cookies